Please login to the form below

dasatinib

This page shows the latest dasatinib news and features for those working in and with pharma, biotech and healthcare.

and leukaemia drug Sprycel (dasatinib) which brought in $558m, also up 14%.

CHMP backs first-line use for AZ’s Tagrisso in lung cancer

There were also new indications approved for UCB’s Cimzia (certolizumab pegol), Amgen’s Prolia (denosumab), BMS’ Sprycel (dasatinib) and Yervoy (ipilimumab), Pfizer’s Xeljanz (tofacitinib), and Novo Nordisk’s Xultophy
NICE backs BMS leukaemia drug Sprycel

Bristol-Myers Squibb's chronic myeloid leukaemia treatment Sprycel (dasatinib) has been approved for NHS use in England and Wales by the National Institute for Health and Care Excellence. ... Access to targeted therapies like dasatinib not only has the
Opdivo drives gain in BMS sales, but business revamp coming

BMS' other growth products also contributed to the sales gains, with melanoma drug Yervoy (ipilimumab) rising 19% to $285m and Sprycel (dasatinib) for leukaemia up 15% to $472m.
England's Cancer Drugs Fund: Fixing a broken system

Bristol-Myers Squibb's Sprycel (dasatinib):. for treatment of lymphoid blast crisis chronic myeloid leukamia.
Pharma condemns Cancer Drugs Fund cuts

Bristol-Myers Squibb. Sprycel (dasatinib). Chronic myeloid leukaemia. Eisai. Halaven (eribulin). Breast cancer.

More from news
Approximately 3 fully matching, plus 29 partially matching documents found.

Interview: Harvey Berger and Timothy Clackson, Ariad

recommended for use in patients who have grown resistance to Tasigna (nilotinib) and Gleevec/Glivec (imatinib mesylate) from Novartis and Bristol-Myers Squibb's Sprycel (dasatinib).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Endocyte brings in senior figures from BMS and Amgen

Hoof was most recently VP global commercialisation at BMS, where he was responsible for the US-based company's haematology franchise, which includes products such as Spyrcel (dasatinib).

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Associate Director - Global Healthcare Consulting: Highly competitive salary

Early Access Program - Regulatory Affairs (EAP-RA): Highly competitive salary

Add my company

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Virtual Patient Engagement Program: A Customer Story: Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?: Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all: The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...

Email:
Password: